FOR IMMEDIATE RELEASE
SynapDx Corporation’s CEO Stanley Lapidus Presents at Inaugural Autism Investment Conference
Discusses Diagnostic Issues at Event Hosted by Autism Speaks
Lexington, MA – February 21, 2013 – SynapDx Corporation is joining a select group of autism-focused companies to present at the inaugural Autism Investment Conference, held today in New York, NY and sponsored by Autism Speaks. SynapDx’s CEO Stanley Lapidus will share his vision for addressing the unmet needs in autism diagnosis as part of the panel entitled “Diagnostics and Enabling Technologies.”
Lapidus will also update the community on SynapDx’s research efforts to further development of its breakthrough blood-based autism spectrum disorder (ASD) diagnostic test, designed to help clinicians identify children with autism earlier than they do today.
SynapDx’s blood-test approach measures differences in RNA gene expression to distinguish between children with a higher risk for ASDs from those without. The test could hasten the diagnostic process and help children at risk for ASDs secure access to the right evaluations and treatment as early as possible.
Open to investors, analysts and executives in the life sciences and healthcare, the Autism Investment Conference is designed to educate the investment community on the scale and diversity of business development opportunity in ASD. Through a series of panels, companies developing products aligned with unmet needs in ASD are able to showcase their efforts and network with investors.
Lapidus’ panel will take place today at 10:45 am ET.
About SynapDx Corp.
SynapDx is a private company providing laboratory diagnostics to physicians who suspect children of developmental disorders, with the initial goal of enabling earlier detection of autism spectrum disorders (ASDs). The company collaborates with ASD experts at leading institutions, including Boston Children’s Hospital.
SynapDx was founded in 2010 and is based in Lexington, Mass. SynapDx’s investors include North Bridge Venture Partners, General Catalyst Partners and LabCorp.
Media Contact
Susan McCarron
Susan_mccarron@lpp.com 617-986-5767
#
More With SynapDx
Loading…
Something went wrong. Please refresh the page and/or try again.
Note/Warning:
Autistic people have fought the inclusion of ABA in therapy for us since before Autism Speaks, and other non-Autistic-led autism organizations, started lobbying legislation to get it covered by insurances and Medicaid.
ABA is a myth originally sold to parents that it would keep their Autistic child out of an institution. Today, parents are told that with early intervention therapy their child will either be less Autistic or no longer Autistic by elementary school, and can be mainstreamed in typical education classes. ABA is very expensive to pay out of pocket. Essentially, Autism Speaks has justified the big price tag up front will offset the overall burden on resources for an Autistic’s lifetime. The recommendation for this therapy is 40 hours a week for children and toddlers.
The original study that showed the success rate of ABA to be at 50% has never been replicated. In fact, the study of ABA by United States Department of Defense was denounced as a failure. Not just once, but multiple times. Simply stated: ABA doesn’t work. In study after repeated study: ABA (conversion therapy) doesn’t work.
What more recent studies do show: Autistics who experienced ABA therapy are at high risk to develop PTSD and other lifelong trauma-related conditions. Historically, the autism organizations promoting ABA as a cure or solution have silenced Autistic advocates’ opposition. ABA is also known as gay conversion therapy.
The ‘cure’ for Autistics not born yet is the prevention of birth.
The ‘cure’ is a choice to terminate a pregnancy based on ‘autism risk.’ The cure is abortion. This is the same ‘cure’ society has for Down Syndrome.
This is eugenics 2021. Instead of killing Autistics and disabled children in gas chambers or ‘mercy killings’ like in Aktion T4, it’ll happen at the doctor’s office, quietly, one Autistic baby at a time. Different approaches yes, but still eugenics and the extinction of an entire minority group of people.
Fact: You can’t cure Autistics from being Autistic.
Fact: You can’t recover an Autistic from being Autistic.
Fact: You can groom an Autistic to mask and hide their traits. Somewhat. … however, this comes at the expense of the Autistic child, promotes Autistic Burnout (this should not be confused with typical burnout, Autistic Burnout can kill Autistics), and places the Autistic child at high risk for PTSD and other lifelong trauma-related conditions.
[Note: Autism is NOT a disease, but a neurodevelopmental difference and disability.]
Fact: Vaccines Do Not Cause Autism.
International Badass Activists 
2 responses to “Archived | SynapDx Corporation’s CEO Stanley Lapidus Presents at Autism Speaks’ Inaugural Autism Investment Conference | Circa February 21, 2013 #NotAnAutisticAlly”
[…] SynapDx Corporation’s CEO Stanley Lapidus Presents at Autism Speaks’ Inaugural Autism Investment Conference […]
LikeLike
[…] SynapDx Corporation’s CEO Stanley Lapidus Presents at Autism Speaks’ Inaugural Autism Investment… […]
LikeLike